Last reviewed · How we verify
NCT04850391: ObeApp
Interaction of Sleep, Diurnal Eating Pattern, Gut Microbiota, and Obesity
NA trial testing Mobile app in Obesity in 133 participants. Completed in 21 October 2024.
21 October 2024
Quick facts
| Lead sponsor | Turku University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 133 |
| Start date | 1 October 2021 |
| Primary completion | 21 October 2024 |
| Estimated completion | 21 October 2024 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Mobile app
Conditions studied
- Obesity — all drugs for Obesity →
- Obesity & Overweight — all drugs for Obesity & Overweight →
Sponsor
Turku University Hospital
Who can join
Adults 18 to 65, any sex, with Obesity or Obesity & Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goals of the proposed study are 1) to provide scientific basis for the relationship between subjective sleep quality, diurnal eating pattern, gut microbiome, and obesity, 2) to develop and test a pragmatic, cost-effective new tool to advance lifestyle changes using E-health approach, and 3) to compare differences in subjective sleep quality, diurnal eating pattern and gut microbiome at baseline 4) to compare changes induced by the E-health intervention among the three study groups and participants with different work schedules.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04850391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mobile app
Trials testing the same drug.
- NCT04519008 — Effectiveness and Security Testing of a Mobile App · NA · not yet recruiting
- NCT07097233 — The Impact of Virtual Reality Haptic Simulators and Mobile Apps in Endodontic Clinical Practice · NA · not yet recruiting
- NCT07041515 — Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome · NA · not yet recruiting
- NCT07113626 — Adapting An Evidence-Based Intervention To Improve HIV Testing And PrEP Uptake In Vietnam · NA · recruiting
- NCT06293183 — The Effect of Artificial Intelligence Supported Mobile Learning on Nutrition/Hydration Control and Individual Management · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Turku University Hospital trials
Trials by the same sponsor.
- NCT07488494 — Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (E · NA · not yet recruiting
- NCT07316868 — Neuroprotective Effect of Mild Hypothermia Versus Normothermia During Cardiopulmonary Bypass of Coronary Artery Surgery · NA · not yet recruiting
- NCT07306000 — Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development · NA · recruiting
- NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
- NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04850391 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Turku University Hospital
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04850391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing